Your browser doesn't support javascript.
loading
Real-world safety and effectiveness of dapagliflozin in people living with type 1 diabetes in Spain: The Dapa-ON multicenter retrospective study.
Durán-Martínez, María; Azriel, Sharona; Doulatram-Gamgaram, Viyey Kishore; Moreno-Pérez, Óscar; Pinés-Corrales, Pedro J; Tejera-Pérez, Cristina; Merino-Torres, Juan Francisco; Brito-Sanfiel, Miguel; Chico, Ana; Marco, Amparo; García-Fernández, Elena; Martínez-Montoro, José Ignacio.
Affiliation
  • Durán-Martínez M; Department of Endocrinology and Nutrition, Getafe University Hospital, Madrid, Spain; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain.
  • Azriel S; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain; Department of Endocrinology and Nutrition, Infanta Sofia University Hospital, Madrid, Spain.
  • Doulatram-Gamgaram VK; Department of Endocrinology and Nutrition, Regional University Hospital of Málaga, Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, Málaga, Spain.
  • Moreno-Pérez Ó; Endocrinology and Nutrition Department, Dr. Balmis General University Hospital - Alicante Institute of Sanitary and Biomedical Research (ISABIAL), Alicante, Spain; Clinical Medicine Department, Miguel Hernández University, Elche, Alicante, Spain.
  • Pinés-Corrales PJ; Department of Endocrinology and Nutrition, Albacete University Hospital, Albacete, Spain.
  • Tejera-Pérez C; Department of Endocrinology and Nutrition, Complejo Hospitalario Universitario de Ferrol (CHUF/SERGAS), A Coruña, Spain; Epigenomics in Endocrinology and Nutrition Group, Epigenomics Unit, Instituto de Investigacion Sanitaria de Santiago de Compostela (IDIS), Complejo Hospitalario Universitario de S
  • Merino-Torres JF; Department of Endocrinology and Nutrition, University and Polytechnic Hospital La Fe, Valencia, Spain; Joint Research Unit On Endocrinology, Nutrition and Clinical Dietetics, University of Valencia-Health Research Institute La Fe, Valencia, Spain; Medicine Department, Universitat de València, Valenc
  • Brito-Sanfiel M; Department of Endocrinology and Nutrition, Puerta de Hierro University Hospital, Madrid, Spain.
  • Chico A; Department of Endocrinology and Nutrition, Hospital Santa Creu i Sant Pau, Barcelona, Spain; CIBER-BBN, Instituto de Salud Carlos III, Madrid, Spain; Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Marco A; Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Spain; Department of Endocrinology and Nutrition, Toledo University Hospital, Toledo, Spain.
  • García-Fernández E; Department of Endocrinology and Nutrition, 12 de Octubre University Hospital, Madrid, Spain.
  • Martínez-Montoro JI; Department of Endocrinology and Nutrition, Virgen de la Victoria University Hospital, Málaga, Spain; Instituto de Investigación Biomédica de Málaga (IBIMA)-Plataforma Bionand, Málaga, Spain; Faculty of Medicine, University of Málaga, Málaga, Spain; Centro de Investigación Biomédica en Red de la Fisi
Diabetes Metab ; 50(1): 101501, 2024 Jan.
Article in En | MEDLINE | ID: mdl-38061425
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / Glucosides Limits: Humans Country/Region as subject: Europa Language: En Journal: Diabetes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Diabetic Ketoacidosis / Diabetes Mellitus, Type 1 / Glucosides Limits: Humans Country/Region as subject: Europa Language: En Journal: Diabetes Metab Journal subject: ENDOCRINOLOGIA / METABOLISMO Year: 2024 Document type: Article Affiliation country: Country of publication: